Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec
  • MACS® Cell Analysis
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
CliniMACS® Prodigy CliniMACS® Prodigy
CliniMACS® Cell Separation System CliniMACS® Cell Separation System
TheraSorb™ Therapeutic Apheresis TheraSorb™ Therapeutic Apheresis
CryoMACS® Freezing Bags CryoMACS® Freezing Bags
MACS® GMP Products MACS® GMP Products
  MACS GMP Antibodies
  MACS GMP Antigens
  MACS GMP Cytokines
  MACS GMP Cell Culture Media
  MACS GMP Cell Culture Bags
  Apoptotic cell removal
  MACS GMP Certificates
Miltenyi Biotec
MACS eNews
Subscribe to our
MACS eNews
for regular product information via e-mail.
Miltenyi Biotec
MACS® GMP PepTivator® HCMV pp65
Overview
The MACS GMP PepTivator HCMV pp65 is a peptide pool that consists mainly of 15-mer peptides with eleven amino-acids overlap. It has been developed for efficient in vitro stimulation and subsequent isolation of HCMV pp65-specific CD4+ and CD8+ T cells.
Details
Background information
Human cytomegalovirus (HCMV) is a member of the herpes virus group and belongs to the subfamily of beta-herpes viruses. Between 50 and 85% of human adults are infected with HCMV. Once infected, the virus persists in the organism. The infection is asymptomatic in healthy individuals but in immunocompromized patients HCMV can cause severe disease.

The pp65 protein (65 kDa lower matrix phosphoprotein), also known as glycoprotein 64 or UL83, is a virion tegument protein and the main component of the enveloped subviral particle. pp65 is an immunodominant target of CD4+ as well as CD8+ T cell responses to HCMV.

Applications

Antigen-specific T cells play a critical role in the regulation of immune responses and the elimination of virus-infected or malignant cells in the human body. Adoptive transfer of clinical-grade pp65-specific CD4+ and CD8+ T cells is a valuable tool for the treatment of HCMV infections after hematopoietic stem cell transplantation (SCT)1,2 and shows potential for solid organ transplantation (SOT)3.

The in vitro stimulation of pp65-specific CD4+ and CD8+ T cells with MACS® GMP PepTivator HCMV pp65 causes the production of the effector cytokine IFN-gamma. The secretion of IFN-gamma then permits the enrichment of pp65-specific effector/memory T cells with the use of the CliniMACS Cytokine Capture System (IFN-gamma).

Quality statement
MACS GMP Products are manufactured and tested under a certified ISO 9001 quality system and in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

No animal-, human-, or virus-derived materials were used for manufacture of these products.
Disclaimer
MACS GMP Products are for research use and ex vivo cell culture processing only, and are not intended for human in vivo applications.
 
Miltenyi Biotec
Search this website
Advanced search
Toolbox
Customer login
Contact
Newsletter
Help
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
MACS GMP PepTivator HCMV pp65
Availability: Worldwide (1)
- 60 nmol/peptide for the stimulation of 109 cells
Download datasheet
170-076-109
Qty.:
 

(1) For availability in your country please contact your local representative.
Related products
MACS® GMP HCMV pp65 - Recombinant Protein
MACS® GMP PepTivator® AdV5 Hexon
CliniMACS® Cytokine Capture System (IFN-gamma) - Product Line
References
1. Einsele et al. (2002) Blood 99: 3916–3922.
2. Mackinnon et al. (2008) Blood Cells Mol. Dis. 40: 63–67.
3. Brestrich et al. (2009) Am J Transplant. Jul;9(7):1679-84.
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website